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Simultaneous determination of phthalate metabolites, parabens and benzophenone-3
in human urine by ultra-high-pressure-liquid-chromatography tandem mass spectrometry
Endocrine disrupting chemicals are substances that can interact with the 
endocrine system causing alteration of the endocrine homeostasis and 
potentially lead to adverse health effects. They have been linked to numbers 
endocrine diseases such as reproductive disorders, infertility, hormone-
dependant cancers, obesity, diabetes, neuro-developmental disorders,…
Phthalates, Parabens and Benzophenone-3 (BP3) have endocrine 
disrupting properties and they are high production volume (HPV) chemicals. 
More than 75% of general population’s urines were found positive for most of 
them leading to an important public health issue
These compounds are rapidly excreted from human body, their analysis in 
urine provides information about recent exposure. To assess human exposure 
and investigate potential endocrine disruptive health injuries, we developed an 
Ultra High Pressure Liquid Chromatography coupled to Tandem Mass
Spectrometry analytical method for simultaneous measurement of phthalate 
metabolites, parabens and BP3 in human urine.
Total error method approach E-noval software (Arlenda)
• Calibration points in duplicate during 3 days :
from 0.5 to 200 µg/L (most compounds) 
from 2 to 800 µg/L (MP, BP3)
• Validation points in triplicate during 3 days :
from 0.2 to 200 µg/L (most compounds) 
from 0.2 to 800 µg/L (MP, BP3)
The acceptance limits were set at 30% for concentration upper of 2 µg/L for EP, PP, MnBP, MEP, 5-oxo-MEHP, 5-OH-MEHP, MEHP, MBzP, BP3 and 5 µg/L for MP, 
MiBP and BP. They were set at 50% for concentration from LOQ to 2 µg/L for EP, PP, MnBP, MEP, 5-oxo-MEHP, 5-OH-MEHP, MEHP, MBzP, BP3 and 5 µg/L for 
MP, MiBP and BP.
UPLC-Acquity (Waters) : 
• Mobile phase: H2O HAc 0.1% / ACN HAc 0.1% (A / B)
• Column:Kinetex 1.7u Phenyl-Hexyl 100A 100x2.1 mm (Phenomenex)
• Flow: 0.55 mL/min, gradient elution mode (from 91% to 20% A), 35°C
• Injection volume: 5 µL
• Run time: 20 min
Tandem MS Quattro Premier XE (Waters) :
• ESI – (-3kV) except for BP3, ESI + (4.0 kV)
• 2 MRM studied by analyte





We developed a sensitive method for determination of seven phthalate metabolites, four parabens and benzophenone-3. This method 
was fully validated according the total error method approach. The three enzymatic conditions were validated. This method can now be 
used for human exposure monitoring and to investigate potential health injuries of these endocrine disrupting chemicals.
E. coli validation results
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Fortifyied Urine at 50 µg/L
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